Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/35239
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Monocyte subtypes predict clinical course and prognosis in human stroke

AutorUrra, Xabier CSIC ORCID; Amaro, Sergio; Gómez-Choco, Manuel; Obach, Víctor; Planas, Anna M. CSIC ORCID; Chamorro, Ángel
Palabras claveMonocyte subtypes
Platelet–monocyte interactions
Prognosis
Stroke
Fecha de publicaciónmay-2009
EditorNature Publishing Group
CitaciónJournal of Cerebral Blood Flow and Metabolism 29(5): 994-1002 (2009)
ResumenThe number of circulating monocytes increases after stroke. In this study, we assessed the time course and phenotype of monocyte subsets and their relationship with the clinical course and outcome in 46 consecutive stroke patients and 13 age-matched controls. The proportion of the most abundant ‘classical’ CD14highCD16− monocytes did not change after stroke, whereas that of CD14highCD16+ monocytes increased and CD14dimCD16+ monocytes decreased. CD14highCD16+ monocytes had the highest expression of TLR2, HLA-DR and the angiogenic marker, Tie-2; CD14dimCD16+ monocytes had the highest expression of costimulatory CD86 and adhesion molecule CD49d. Platelet–monocyte interactions were highest in CD14highCD16− monocytes and lowest in CD14dimCD16+ monocytes. In adjusted models, 1/CD14highCD16− monocytes were associated with poor outcome (OR: 1.38), higher mortality (OR: 1.40) and early clinical worsening (OR: 1.29); 2/CD14highCD16+ monocytes were inversely related to mortality (OR: 0.32); and 3/CD14dimCD16+ monocytes were inversely related to poor outcome (OR: 0.74) and infarction size (r=−0.45; P=0.02). These results illustrate that the predominant monocyte subtype conveys harmful effects after stroke, which include stronger interaction with platelets. Alternatively, rarer subpopulations of monocytes are beneficial with a phenotype that could promote tissue repair and angiogenesis. Therefore, monitoring of monocyte subtypes may emerge as a useful tool at the bedside for stroke patients.
Descripciónet al.
Versión del editorhttp://dx.doi.org/10.1038/jcbfm.2009.25
URIhttp://hdl.handle.net/10261/35239
DOI10.1038/jcbfm.2009.25
ISSN0271-678X
E-ISSN1559-7016
Aparece en las colecciones: (IIBB) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

155
checked on 22-abr-2024

WEB OF SCIENCETM
Citations

158
checked on 29-feb-2024

Page view(s)

301
checked on 24-abr-2024

Download(s)

68
checked on 24-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.